Tumor-nekrose-faktor alpha bei chronischer herzinsuffizienz. Klinische manifestation und therapeutische möglichkeiten

Translated title of the contribution: Tumor necrosis factor-alpha in chronic heart failure. Clinical manifestations and therapeutic options

Sabine Genth-Zotz, Aidan P. Bolger, Stefan D. Anker

Research output: Contribution to journalArticle

Abstract

Background: Chronic heart failure (CHF) may be seen as a multi-system disorder with its origin in the heart but including many extracardiac manifestations. Immunological abnormalities are recognized in this context, in particular, changes in the expression of mediators of the innate immune response. Importance of TNF: Higher levels of the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF) are found in the circulation and in the myocardium of patients with chronic heart failure than in controls. TNF has been implicated in a number of pathophysiological processes that are thought to be important to the progression of chronic heart failure. Therapies directed against this cytokine might therefore represent anovel approach to heart failure management.

Translated title of the contributionTumor necrosis factor-alpha in chronic heart failure. Clinical manifestations and therapeutic options
Original languageGerman
Pages (from-to)437-446
Number of pages10
JournalHerz
Volume26
Issue number7
Publication statusPublished - 2001

Keywords

  • Chronic heart failure
  • Tumor necrosis factor-alpha

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Tumor necrosis factor-alpha in chronic heart failure. Clinical manifestations and therapeutic options'. Together they form a unique fingerprint.

Cite this